Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Motor Neuron Disease, Amyotrophic Lateral Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06318585
What this trial is testing

Creation of a Clinical Database for the Study of Phenotypic Variability in Motor Neuron Diseases

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
Istituto Auxologico Italiano 200
Testing effectiveness (Phase 2)Study completedNCT01281631
What this trial is testing

NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Neuraltus Pharmaceuticals, Inc. 136
Not applicableNo Longer AvailableNCT03537807
What this trial is testing

Expanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc.
Not applicableActive Not RecruitingNCT04875416
What this trial is testing

Phenotype, Genotype and Biomarkers 2

Who this might be right for
Amyotrophic Lateral SclerosisHereditary Spastic ParaplegiaPrimary Lateral Sclerosis+2 more
University of Miami 217
Not applicableStudy completedNCT05404867
What this trial is testing

Study of Structural and Functional Brain Connectivity Changes in ALS (CoALS-II)

Who this might be right for
Amyotrophic Lateral Sclerosis
Dartmouth-Hitchcock Medical Center 31
Not applicableLooking for participantsNCT06147843
What this trial is testing

French-German Cohort Study to Determine Factors Associated With Weight Loss in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Limoges 1,000
Testing effectiveness (Phase 2)Study completedNCT00214110
What this trial is testing

Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
University of Wisconsin, Madison 100
Not applicableStudy completedNCT02360891
What this trial is testing

Study of Predictive Factors of Progression of Motor Neurone Disease

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron Disease
University Hospital, Lille 500
Not applicableStudy completedNCT01699451
What this trial is testing

DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Mayo Clinic 33
Early research (Phase 1)Study completedNCT01511029
What this trial is testing

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

Who this might be right for
Amyotrophic Lateral Sclerosis
Knopp Biosciences 68
Large-scale testing (Phase 3)Ended earlyNCT03948178
What this trial is testing

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Who this might be right for
Amyotrophic Lateral Sclerosis
Orion Corporation, Orion Pharma 227
Not applicableStudy completedNCT03613038
What this trial is testing

A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria

Who this might be right for
Amyotrophic Lateral SclerosisParkinson Disease
University of Missouri-Columbia 100
Testing effectiveness (Phase 2)UnknownNCT04952155
What this trial is testing

Low Dose IL-2 in the Treatment of Immune-associated ALS Syndrome

Who this might be right for
Amyotrophic Lateral Sclerosis
Peking University Third Hospital 13
Not applicableUnknownNCT05423678
What this trial is testing

Clinical Trial - Analyzing Participation Experiences Of Amyotrophic Lateral Sclerosis Patients

Who this might be right for
ALSAmyotrophic Lateral Sclerosis
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)Study completedNCT01786174
What this trial is testing

Gilenya in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Massachusetts General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00140218
What this trial is testing

R(+) Pramipexole in Early Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Bennett, James P., Jr., M.D., Ph.D. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07023835
What this trial is testing

Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Zydus Therapeutics Inc. 240
Post-approval studies (Phase 4)Study completedNCT01811355
What this trial is testing

Mexiletine for the Treatment of Muscle Cramps in ALS

Who this might be right for
Muscle Cramps in Amyotrophic Lateral Sclerosis
Bjorn Oskarsson, MD 23
Not applicableStudy completedNCT02789059
What this trial is testing

Muscle Oxygenation in Effort in Neuromuscular Diseases

Who this might be right for
Neuromuscular Diseases
University Hospital, Lille 17
Not applicableStudy completedNCT02507713
What this trial is testing

Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Universidad Católica San Antonio de Murcia 60
Next Page